Quarterly report · Q3
3055.TEDINET S100SUQB
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥209.2bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥262.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥199.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥2.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.9bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥151.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥137.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥146.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥92.6bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥80.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥59.3bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥57.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥57.6bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.5bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥4.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥828m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.2bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥856m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥865m | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥835m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥808m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥82.9 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.9 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.41 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.94 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.72 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 39.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-12-31 | ¥1.6bn |
| Otherother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥44m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥1.5bn |
| Otherother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥516m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥10.1bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥10.1bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥113m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥369m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥794m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥48m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥49.0bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥48.6bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥401m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥911m |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥3m |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥217m |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥153.6bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥146.9bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥218.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥209.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥1.9bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥46m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥819m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥10.2bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.2bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥14m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥362m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥825m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥25m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥49.2bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥48.9bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥379m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥295m |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥143.5bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥136.6bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.9bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥209.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥199.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 517
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 2828800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21556700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 215567 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 14500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 24400000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 215567 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 2828800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 2828800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1159 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 2828800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 2828800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1159 | |
| Cash and deposits | Prior1YearInstant | 18022000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 19472000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 54990000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 61946000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 17388000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 20059000000 | JPY |
| Work in process | Prior1YearInstant | 1000000 | JPY |
| Work in process | CurrentQuarterInstant | 9000000 | JPY |
| Other ca | Prior1YearInstant | 7914000000 | JPY |
| Other ca | CurrentQuarterInstant | 8143000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -12000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -26000000 | JPY |
| Current assets | Prior1YearInstant | 98305000000 | JPY |
| Current assets | CurrentQuarterInstant | 109604000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 9940000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 9578000000 | JPY |
| Land | Prior1YearInstant | 9914000000 | JPY |
| Land | CurrentQuarterInstant | 11627000000 | JPY |
| Construction in progress | Prior1YearInstant | 465000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 684000000 | JPY |
| Other net ppe | Prior1YearInstant | 799000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 800000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 21118000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 22691000000 | JPY |
| Goodwill | Prior1YearInstant | 960000000 | JPY |
| Goodwill | CurrentQuarterInstant | 878000000 | JPY |
| Software | Prior1YearInstant | 457000000 | JPY |
| Software | CurrentQuarterInstant | 474000000 | JPY |
| Other ia | Prior1YearInstant | 346000000 | JPY |
| Other ia | CurrentQuarterInstant | 363000000 | JPY |
| Intangible assets | Prior1YearInstant | 1764000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 1716000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |